HUP0301810A2 - Anetol-ditioletion alkalmazása gyógyszer által kiváltott ín-toxicitás megelżzésénél és kezelésénél - Google Patents
Anetol-ditioletion alkalmazása gyógyszer által kiváltott ín-toxicitás megelżzésénél és kezelésénélInfo
- Publication number
- HUP0301810A2 HUP0301810A2 HU0301810A HUP0301810A HUP0301810A2 HU P0301810 A2 HUP0301810 A2 HU P0301810A2 HU 0301810 A HU0301810 A HU 0301810A HU P0301810 A HUP0301810 A HU P0301810A HU P0301810 A2 HUP0301810 A2 HU P0301810A2
- Authority
- HU
- Hungary
- Prior art keywords
- dithiolethione
- anethole
- preventing
- treating drug
- toxicity
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 2
- 230000001988 toxicity Effects 0.000 title abstract 2
- 231100000419 toxicity Toxicity 0.000 title abstract 2
- 210000002435 tendon Anatomy 0.000 title 1
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 abstract 2
- LZENMJMJWQSSNJ-UHFFFAOYSA-N 3H-1,2-dithiole-3-thione Chemical compound S=C1C=CSS1 LZENMJMJWQSSNJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940011037 anethole Drugs 0.000 abstract 1
- 239000000411 inducer Substances 0.000 abstract 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Lubricants (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
A találmány tárgya anetol-ditioletion alkalmazása olyan gyógyszerelőállítására, amely egy induktor gyógyszer által kiváltottintoxicitás megelőzésére vagy kezelésére szolgál. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0005247A FR2807944B1 (fr) | 2000-04-25 | 2000-04-25 | Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenotoxicite induite par un medicament |
PCT/FR2001/001268 WO2001080856A2 (fr) | 2000-04-25 | 2001-04-25 | Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenoxicite induite par un medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0301810A2 true HUP0301810A2 (hu) | 2003-09-29 |
Family
ID=8849561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0301810A HUP0301810A2 (hu) | 2000-04-25 | 2001-04-25 | Anetol-ditioletion alkalmazása gyógyszer által kiváltott ín-toxicitás megelżzésénél és kezelésénél |
Country Status (12)
Country | Link |
---|---|
US (1) | US20030187067A1 (hu) |
EP (1) | EP1351680B8 (hu) |
JP (1) | JP2003531172A (hu) |
AT (1) | ATE297727T1 (hu) |
AU (1) | AU2001256406A1 (hu) |
CA (1) | CA2406998A1 (hu) |
DE (1) | DE60111571T2 (hu) |
ES (1) | ES2245361T3 (hu) |
FR (1) | FR2807944B1 (hu) |
HU (1) | HUP0301810A2 (hu) |
PT (1) | PT1351680E (hu) |
WO (1) | WO2001080856A2 (hu) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103113360B (zh) * | 2013-02-19 | 2015-01-28 | 东南大学 | 一种阿托伐他汀衍生物、其药物组合物及制药应用 |
US11554106B2 (en) * | 2017-03-07 | 2023-01-17 | Marc Childs | Prevention of the risks associated with drug-induced QT interval prolongation by using a specific inhibitor of the production of ROS of miochondrial origin |
WO2018162846A1 (fr) * | 2017-03-07 | 2018-09-13 | Sauzieres, Jacques | Prévention des effets adverses des especes reactives de l'oxygene d'origine mitochondriale à l'aide d'un inhibiteur specifique de la production de ros d'origine mitochondriale |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP9601808A3 (en) * | 1995-07-03 | 2000-06-28 | Sankyo Co | Treatment of arteriosclerosis and xanthoma |
-
2000
- 2000-04-25 FR FR0005247A patent/FR2807944B1/fr not_active Expired - Lifetime
-
2001
- 2001-04-25 AT AT01929703T patent/ATE297727T1/de not_active IP Right Cessation
- 2001-04-25 ES ES01929703T patent/ES2245361T3/es not_active Expired - Lifetime
- 2001-04-25 WO PCT/FR2001/001268 patent/WO2001080856A2/fr active IP Right Grant
- 2001-04-25 PT PT01929703T patent/PT1351680E/pt unknown
- 2001-04-25 US US10/258,520 patent/US20030187067A1/en not_active Abandoned
- 2001-04-25 AU AU2001256406A patent/AU2001256406A1/en not_active Abandoned
- 2001-04-25 JP JP2001577955A patent/JP2003531172A/ja not_active Withdrawn
- 2001-04-25 HU HU0301810A patent/HUP0301810A2/hu unknown
- 2001-04-25 DE DE60111571T patent/DE60111571T2/de not_active Expired - Fee Related
- 2001-04-25 EP EP01929703A patent/EP1351680B8/fr not_active Expired - Lifetime
- 2001-04-25 CA CA002406998A patent/CA2406998A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FR2807944B1 (fr) | 2003-06-13 |
ES2245361T3 (es) | 2006-01-01 |
EP1351680B8 (fr) | 2005-08-17 |
EP1351680A2 (fr) | 2003-10-15 |
CA2406998A1 (fr) | 2001-11-01 |
PT1351680E (pt) | 2005-10-31 |
DE60111571T2 (de) | 2006-05-11 |
ATE297727T1 (de) | 2005-07-15 |
JP2003531172A (ja) | 2003-10-21 |
DE60111571D1 (de) | 2005-07-21 |
WO2001080856A2 (fr) | 2001-11-01 |
WO2001080856A3 (fr) | 2003-04-24 |
US20030187067A1 (en) | 2003-10-02 |
FR2807944A1 (fr) | 2001-10-26 |
AU2001256406A1 (en) | 2001-11-07 |
EP1351680B1 (fr) | 2005-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60124684D1 (de) | Sulfonamido-substituierte verbrückte bicycloalkylderivative | |
PL372925A1 (en) | Prevention and treatment of restenosis by local administration of drug | |
HUP0202570A1 (hu) | Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk | |
BR0309581A (pt) | Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c | |
EA200100572A1 (ru) | Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии | |
CL2004001174A1 (es) | Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia | |
BR0209468A (pt) | Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar | |
NO20034204D0 (no) | Farmasöytiske kombinasjoner til behandling av kreft | |
NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
ATE227277T1 (de) | Isoxazoline derivate und ihre verwendung als antimikroben | |
DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
HUP0300848A2 (hu) | Kamptotecint és egy pirimidinszármazékot tartalmazó készítmény rák kezelésére | |
LV11728A (lv) | Farmaceitiska kompozicija | |
ATE319473T1 (de) | Melagatran zur behandlung von entzündungen | |
ATE357912T1 (de) | Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten | |
HUP0002836A2 (hu) | Makrociklusos bisz(3,3'-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására | |
HUP0301810A2 (hu) | Anetol-ditioletion alkalmazása gyógyszer által kiváltott ín-toxicitás megelżzésénél és kezelésénél | |
DE60142308D1 (de) | Vorbeugungs- oder heilmittel gegen endometriose | |
HUP0302738A2 (hu) | SARP-1 alkalmazása scleroderma kezelésére és megelőzésére | |
HUP0400528A2 (hu) | Neuropeptidáz Y inhibitor alkalmazása férfiak szexuális funkciózavarának kezelésére alkalmas gyógyszerkészítmény előállítására | |
HUP0302241A2 (hu) | CCR5 antagonista és DP-178 polipeptid alkalmazása vírusos fertőzések kezelésére | |
BR0211836A (pt) | Inibidor de anidrase carbÈnica | |
DE69928685D1 (de) | Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit | |
DK1196176T5 (da) | Anvendelse af beta-naphthoquinonderivater til fremstilling af lægemidler, der har en hæmmende virkning på hjernens afgivelse af glutamat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |